Clinical Trial Update: The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

View source ↗

Summary

Clinical trial evaluating the effect of adalimumab on bone microstructure in Crohn's disease patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Gerhard Rogler | Conditions: Crohn's Disease | Status: TERMINATED